Saturday, March 20, 2010

Pushing Taxpayer-funded Teen-sex Vaccine

Mainstream media advocates deadly vaccine enabling sexual immorality for underprivileged children

-- From "Poorer girls not getting HPV vaccine for cervical cancer" by Liz Szabo, USA TODAY 3/18/10

A cervical cancer vaccine is not getting to many of the girls who need it the most, a new study shows.

Mississippi and Arkansas, two of the nation's poorest states, also have the highest death rates from cervical cancer — a result of poor access to basic screenings and health care for a large number of women, says Peter Bach of New York's Memorial Sloan-Kettering Cancer Center.

Yet in Mississippi, where the vaccine could perhaps save the greatest number of lives, only 16% of teen girls in 2008 received the shot, called Gardasil, according to Bach's paper in Saturday's The Lancet. About 22% of Arkansas girls ages 13 to 17 got the vaccine, which costs $390 for three shots.

. . . women's health activist Barbara Brenner of Breast Cancer Action says Bach's study highlights broad inequalities in American health care. "There are places in this country where women have nothing," Brenner says. "But we don't notice them until a story like this comes out."

To read the entire article above, CLICK HERE.

From "One More: USA Today Joins in Misreporting Gardasil" by Sarah Knoploh, NewsBusters 3/19/10

When the vaccine Gardasil was first introduced, the mainstream media wasted no time falsely touting it as a cure for cervical cancer. The dangerous side effects of Gardasil – including death – were also ignored. Even though the side effects are now known, a March 18 article in USA Today by Liz Szabo worried about girls who are not receiving the vaccine.

. . . a National Vaccine Information Center (NVIC) study in February of 2009 . . . found that 29 known cases in which patients have died after receiving Gardasil. Szabo never mentioned a single one of those deaths.

And it’s not just deaths that Gardasil causes. According to NVIC press release: “Nearly 90 percent of all Gardasil recipients and 85 percent of aluminum placebo recipients reported one or more adverse events within 15 days of vaccination, particularly at the injection site. Pain and swelling at injection site and fever occurred in approximately 83 percent of Gardasil and 73 percent of aluminum placebo recipients. About 60 percent of those who got Gardasil or the aluminum placebo had systemic adverse events including headache, fever, nausea, dizziness, vomiting, diarrhea, myalgia. Gardasil recipients had more serious adverse events such as headache, gastroenteritis, appendicitis, pelvic inflammatory disease, asthma, bronchospasm and arthritis.”

To read the entire article above, CLICK HERE.